ApprovalTrail

Company · Hamilton, Ontario, Canada

Centre For Probe Development And Commercialization

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
6
2 authorized now
Natural health products
0
0 active licences
Medical device licences
0
0 active
Notices of Compliance
6

Drug products

Authorized products first.

NameDINStatus
OSTEOVISIONStatus since Jul 202102462141Dormant
PROSTALUMINStatus since Sep 202602571757Approved
GLUCOVISION (CITRATE)Status since Nov 202002328771Cancelled Post Market
GLUCOVISION (CITRATE)Status since Nov 202002486644Cancelled Post Market
GLUCOVISION (PHOSPHATE)Status since Nov 202002486652Cancelled Post Market
GLUCOVISION (PHOSPHATE)Status since Nov 202002486660Cancelled Post Market

Notices of Compliance

Newest first.

  • PROSTALUMINSeptember 24, 2026 · NOC 38346 · New Drug Submission (NDS)
  • OSTEOVISIONMarch 9, 2017 · NOC 19038 · Abbreviated New Drug Submission (ANDS)
  • FLUOROHMETAugust 6, 2014 · NOC 15915 · New Drug Submission (NDS)
  • GLUCOVISIONMarch 13, 2013 · NOC 14214 · Supplement to a New Drug Submission (SNDS)
  • GLUCOVISIONJuly 2, 2010 · NOC 11571 · New Drug Submission (NDS)
  • 99MTC SULPHIDE COLLOID KITJuly 2, 2010 · NOC 11576 · New Drug Submission (NDS)

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.